HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High prevalence of accelerated silicosis among gold miners in Jiangxi, China.

AbstractBACKGROUND:
Accelerated silicosis has become uncommon in developed countries, whereas serious health threat still exists in small-scale mining in developing countries. This study was to investigate the prevalence and risk factors of accelerated silicosis among Chinese gold miners.
METHODS:
A cross-sectional medical examination was conducted among 574 Chinese gold miners. All participants were male rock-drillers. The concentrations of total dust and quartz content were obtained from the government documentations. Descriptive data analyses were performed.
RESULTS:
The prevalence of accelerated silicosis was 29.1% (95% CI: 24.8-33.4%, 167 cases) after an average of 5.6 years of dust exposure, and a history of tuberculosis seemed to increase the risk. The concentration of respirable silica dust was estimated to be 89.5 mg/m(3) (ranged: 70.2-108.8) in the underground goldmine, far exceeding the permissible exposure limits.
CONCLUSIONS:
This study illustrates a serious health threat to small-scale goldmine in China and indicates an urgent need for environmental control and disease prevention.
AuthorsLap Ah Tse, Zhi Min Li, Tze Wai Wong, Zhen Ming Fu, Ignatius Tak Sun Yu
JournalAmerican journal of industrial medicine (Am J Ind Med) Vol. 50 Issue 12 Pg. 876-80 (Dec 2007) ISSN: 0271-3586 [Print] United States
PMID17948247 (Publication Type: Journal Article)
Chemical References
  • Dust
  • Gold Compounds
  • Silicon Dioxide
Topics
  • China (epidemiology)
  • Cross-Sectional Studies
  • Dust
  • Gold Compounds
  • Humans
  • Male
  • Mining
  • Occupational Exposure (adverse effects)
  • Occupational Health
  • Prevalence
  • Risk Assessment
  • Risk Factors
  • Silicon Dioxide (toxicity)
  • Silicosis (diagnosis, epidemiology, etiology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: